Pyran, Inc., a high-growth company that creates high-performing 5-carbon products made from renewable resources, today announced that it has closed its latest round of fundraising, bringing its total of investments and grants to nearly $4 million....
Madison-based FluGen has been awarded a $11.4 million grant from the Department of Defense to study the ability of its experimental flu vaccine to protect against drifted flu virus strains in older adults, the company said Thursday....
Nimble Therapeutics and RayzeBio today announced the companies have entered a strategic collaboration to discover and develop novel peptide-based radiopharmaceuticals for treatment of cancer....
The latest edition of “The Wisconsin Portfolio” shows more than $483 million was raised by the state’s early stage companies in 2020, a record for any calendar year in Wisconsin but still not on par with other Midwest states....
Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. ...
Today, the U.S. Food and Drug Administration approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated....
New guidelines have moved the recommended age to start getting screened for colon cancer from age 50 to 45, which could also have major implications for Madison-based Exact Sciences Corp., the biotech company behind the at-home colon cancer screening test Cologuard....
The Wisconsin Idea is the notion that the benefits of the University of Wisconsin should ripple well beyond the borders of campus. If you wanted to see the Wisconsin Idea in action, you could visit University Research Park....
At the latest “First Look Forum” produced by three of Milwaukee’s leading research universities, three of the six presenting research teams offered solutions to cleaning water – from drinking water at home and abroad to untreated sewage discharges often triggered by storms....
Madison company started by a UW Health transplant surgeon aims to develop a gene therapy for type 1 diabetes, with the goal of regulating glucose metabolism without the need for daily insulin shots. The company is based at Forward Biolabs, a biotech business incubator at...